Modest RNF11 expression was seen in 63% of the head and neck tumours, and 57% of the lung tumours, whereas renal and prostate carcinomas stained only weakly positive for RNF11 protein (∼10%) (Figure 1B, Table 1). Here, RNF11 is linked to head and neck neoplasm.